Highlights and Quick Summary
- Non-current Revenue (Deferred) for the quarter ending December 31, 2018 was $54 Thousand (a -33.33% decrease compared to previous quarter)
- Year-over-year quarterly Non-current Revenue (Deferred) decreased by -58.78%
- Annual Non-current Revenue (Deferred) for 2018 was $54 Thousand (a -65.16% decrease from previous year)
- Annual Non-current Revenue (Deferred) for 2017 was $155 Thousand (a -98.16% decrease from previous year)
- Annual Non-current Revenue (Deferred) for 2016 was $8.43 Million (a -15.75% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-current Revenue (Deferred) of BioCryst Pharmaceuticals, Inc.
Most recent Non-current Revenue (Deferred)of BCRX including historical data for past 10 years.Interactive Chart of Non-current Revenue (Deferred) of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Non-current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2018 | $0.05 | $0.08 | $0.11 | $0.13 | $0.05 |
| 2017 | $0.16 | $0.47 | $7.79 | $8.11 | $0.16 |
| 2016 | $8.43 | $8.75 | $9.07 | $9.51 | $8.43 |
| 2015 | $10.0 | $10.47 | $10.32 | $3.63 | $10.0 |
| 2014 | $3.95 | $3.85 | $4.14 | $4.44 | $3.95 |
| 2013 | $4.74 | $5.03 | $5.33 | $5.62 | $4.74 |
| 2012 | $5.92 | $6.22 | $6.51 | $6.81 | $5.92 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology